The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Dr. Dean L. Fanelli, Founding Partner, Fanelli Haag PLLC will speak at the Knowledge Congress' webcast entitled: "Patent Protection for Pharma and Biotechnology in 2016 LIVE Webcast."  This event is scheduled for Monday, April 18, 2016 @ 3:00 PM to 5:00 PM (ET).

For further details, please visit:

About Dr. Dean L. Fanelli

Dean L. Fanelli, Ph.D. is a Founding Partner of the Fanelli Haag PLLC whose practice focuses on issues facing the biotechnology, pharmaceutical, and chemical industries.  Dr. Fanelli's expertise lies in patent portfolio creation and management, counseling, technology transactions, due diligence, and opinion work, including drafting novelty, freedom-to-operate, and invalidity opinions.  Dr. Fanelli also has significant experience with the interplay between patent and FDA laws under the Hatch-Waxman Act, and he regularly handles IP issues attendant to mergers, acquisitions, and financing for life sciences companies as well as pre-litigation ANDA analyses associated with Hatch-Waxman paragraph IV litigation.  Dr. Fanelli also has expertise with medical products, chemical compounds, polymer compositions, food additives and cosmetic compositions.  Dr. Fanelli gained additional experience in strategic patent management and licensing while working in-house with an international pharmaceutical drug-delivery company and while working with a major consumer product company.

About Fanelli Haag PLLC

FANELLI Haag PLLC focuses on intellectual property and provides our clients with the highest caliber of legal representation together with the responsiveness, dedication, efficiency and versatility that only a smaller firm can offer.   Our approach is a strategic one.  We are uniquely positioned to provide solutions that not only meet, but anticipate, the needs of our clients. Our seamlessly integrated team of attorneys is able to efficiently partner with our clients to craft comprehensive rationally-designed intellectual property strategies.  Strong scientific backgrounds, as well as years of legal experience working with the United States Patent and Trademark Office, top-tier international law firms and as venture capitalists and in-house counsel, allow our lawyers to work closely with our clients to understand their technical, business, and legal goals.  The Firm provides a range of intellectual property services relating to patent prosecution, pre-investment due diligence investigations, freedom-to-operate analyses, opinion work and IP-sales/licensing transactions.

Event Synopsis:

The biotechnology industry is a dynamic sector that creates stable jobs and opens opportunities for economic growth in many different countries, particularly in America. Without a robust and strongly enforceable patent protection, investment in biotech innovation may decrease.

Ironically, though, in 2015, the biotech sector has seen an erosion of patent rights due to Supreme Court decisions. Despite this and other threats to both biotech and pharmaceutical patents, companies are turning for help in dealing with the increasing number of patent validity challenges and post-grant review proceedings.

In this overly-competitive patent landscape, protecting pharmaceutical and biotechnology innovation demands for effective strategies.

In this two-hour LIVE Webcast, The Knowledge Group has assembled a panel of key thought leaders that will help pharma and biotech companies understand the critical issues on Patent Protection for Pharma and Biotechnology. They will also offer best strategies and practices with regards to this significant topic.

In this LIVE Webcast, the speakers will discuss:

• Notable Supreme Court Decisions Affecting Pharma and Biotech Industry

• Mayo Collaborative Servs. v. Prometheus Labs., Inc.
• Molecular Pathology v. Myriad Genetics
• Limelight Networks, Inc v. Akamai Technologies, Inc.

• Patent Protection Challenges Post Mayo, Myriad and Limelight
• Best Strategies on Protecting Patent for Pharma and Biotech Innovation
• Up-to-date Legislative Trends on Pharma and Biotech Patents

About The Knowledge Group/The Knowledge Congress Live Webcast Series

The Knowledge Congress was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: